City Therapeutics has inked a new deal with Bausch + Lomb for a gene silencing approach to the eye disorder geographic atrophy (GA). The early-stage deal breaks down like this: City gets an ...
The collaboration may expand into other ocular conditions. Character Biosciences announced a collaboration with Bausch + Lomb with an initial focus on developing innovative treatments for age ...
City Therapeutics will develop a novel RNAi clinical candidate toward a specific disease target for intravitreal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback